Mass Tort Journal

  • Subscribe
  • Search
  • Menu
All Access
  • Home
  • Courtroom News
  • Litigation
  • Breaking News
  • Science & Medicine
  • Policy & Legislation
ALSO SEE

Does Off-Label Promotion Settlement Signal Change in FDA Policy?

Science & Medicine
Reuters | Aug 10, 2017
Young farmer in soybean fields

Weed Killer ‘Crisis’ Expected to Lead to More Lawsuits

As the U.S. growing season entered its peak this summer, farmers began posting startling pictures on social media: fields of beans, peach orchards and vegetable gardens withering away

Science & Medicine
New York TImes | Jun 6, 2017

EpiPen Maker to FDA, Congress, Critics: “Go F**k Yourself!”

Mylan has an effective monopoly on a lifesaving product, which has allowed its leaders to see public outrage as a tax they must pay.

Science & Medicine
STAT | May 11, 2017

Over 30% of Drugs Have Safety Issues After Approval

Researchers at the Yale School of Medicine found that nearly a third of medications that reached the market from 2001 through 2010 had major safety issues years after they became widely available to patients.

Science & Medicine
Forbes | Feb 6, 2017

Doctors Question Efficacy of Morning Sickness Drug

Kim Kardashian might have sworn by it, but Dr. Nav Persaud says there's no evidence that the only prescription drug approved to treat morning sickness works.

Science & Medicine
The Intercept | Dec 13, 2016

Are “Patient Advocacy” Groups a Big Pharma Scam?

The Project on Government Oversight finds that almost all patient advocacy groups engaged in the FDA agency review processes for prescription drugs received funding from pharmaceutical companies.

Science & Medicine
The Center for Public Integrity | Dec 2, 2016

Drugmakers “Delay and Defend” Efforts by Lawmakers to Fight Opioid Crisis

Makers of prescription painkillers have tried to weaken state measures aimed at stemming the opioid crisis that has killed 165,000.

Science & Medicine
StatNews | Nov 4, 2016

Is Genetic Testing Leading to Unnecessary and Even Harmful Treatment?

Problems with the databases used to interpret patients’ genetic profiles can lead to inappropriate treatment with devastating consequences, researchers say.

Science & Medicine
Forbes | Nov 4, 2016
Jupiterimages-Pixland-Thinkstock

Opinion: Big Pharma Has Broken Its Social Contract

The pharmaceutical industry must restore the social contract governing its business practices and lower drug prices so Americans can better afford medication.

  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »

© 2025 · Mass Tort Journal · All Rights Reserved

  • All Access
  • Courtroom News
  • Litigation
  • Policy & Legislation
  • Science & Medicine
  • Home
  • Breaking News
  • Litigation
  • Courtroom News
  • Science & Medicine
  • Policy & Legislation